Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-19T23:29:02.954Z Has data issue: false hasContentIssue false
  • English
  • Français

Developing medicines for agitation and aggression in Alzheimer's disease

Published online by Cambridge University Press:  31 December 2014

DAVID AMES
DAVID AMES*
Affiliation:
Director National Ageing Research Institute and University of MelbourneProfessor of Ageing and Health, Former Editor in Chief and current Book Review Editor for International Psychogeriatrics, National Ageing Research Institute, Parkville, Victoria, Australia Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary paper of the month
Information
International Psychogeriatrics , Volume 27 , Issue 2 , February 2015 , pp. 179
Copyright
Copyright © International Psychogeriatric Association 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ames, D., Burns, A. and O’Brien, J. T. (2010). Dementia, 4th edn. London: Hodder Arnold.Google Scholar
Atti, A. R. et al. (2014). A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia. International Psychogeriatrics, 26, 19–37. doi: 10.1017/S1041610213001658.Google Scholar
Carrasco-Garrido, P., López de Andrés, A., Barrera, V. H., Jiménez-Trujillo, I. and Jiménez-Garcia, R. (2013). National trends (2003–2009) and factors related to psychotropic medication use in community dwelling elderly population. International Psychogeriatrics, 25, 328–338. doi: 10.1017/S104161021200169X.Google Scholar
Kröpelin, T. F., Neyens, J. C. L., Halfens, R. J. G., Kempen, G. I. J. M. and Hamers, J. P. H. (2013). Fall determinants in older long-term care residents: a systematic review. International Psychogeriatrics, 25, 549–563. doi: 10.1017/S1041610212001937.CrossRefGoogle ScholarPubMed
Seitz, D. P. et al. (2013). Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. International Psychogeriatrics, 25, 185–203. doi: 10.1017/S1041610212001627.Google Scholar
Selbaek, G., Engedal, K., Benth, J. S. and Bergh, S. (2014). The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period. International Psychogeriatrics, 26, 81–91. doi: 10.1017/S1041610213001609.Google Scholar
Testad, I. et al. (2014). The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review. International Psychogeriatrics, 26, 1083–1099. doi: 10.1017/S1041610214000131.Google Scholar
Truzzi, A. et al. (2013). Patterns of neuropsychiatric sub-syndromes in Brazilian and Norwegian patients with dementia. International Psychogeriatrics, 25, 228–235. doi: 10.1017/S1041610212001640.Google Scholar